As of 9:06:46 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 20 | 13 | 21 | 23 |
| Avg. Estimate | 3.26B | 3.64B | 13.41B | 15.7B |
| Low Estimate | 3.03B | 3.3B | 13.16B | 13.64B |
| High Estimate | 3.61B | 4B | 13.74B | 17.48B |
| Year Ago Sales | 2.42B | 3.06B | 10.77B | 13.41B |
| Sales Growth (year/est) | 34.53% | 18.86% | 24.46% | 17.12% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CV0.F | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | Evercore ISI Group: In-Line to In-Line | 12/3/2024 |
| Upgrade | Morgan Stanley: Underweight to Equal-Weight | 11/5/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 10/31/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 10/31/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 10/31/2024 |
| Maintains | Needham: Buy to Buy | 10/31/2024 |